000513:SZSELivzon Pharmaceutical Group Inc. Analysis
Data as of 2026-09-06 - not real-time
CN¥26.77
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Livzon Pharmaceutical Group Inc. trades at ¥26.77, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 10.6%. With RSI at 35.4 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near ¥25.74 and resistance around ¥31.27.
The shares look undervalued, trading on 14.2 times earnings below a sector average of 30.6. The average analyst target implies 27.1% above today's level. Revenue is contracting at 31.1% on a 15.6% profit margin. The 5.34% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 37.9%, a beta of 0.07 and a maximum drawdown of 37.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
The shares look undervalued, trading on 14.2 times earnings below a sector average of 30.6. The average analyst target implies 27.1% above today's level. Revenue is contracting at 31.1% on a 15.6% profit margin. The 5.34% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 37.9%, a beta of 0.07 and a maximum drawdown of 37.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Top Market Events
Investing28dLivzon Pharmaceutical Group IncWe've identified the following companies as similar to Livzon Pharmaceutical...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 32.90
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 14.2 versus sector average of 30.6
- Trading below the 200-day average of 32.90
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 14.2 versus sector average of 30.6
- Analyst targets imply +27.1% versus the current price
- Profit margin of 15.6% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-31.10%
Profit Margin15.58%
P/E Ratio14.2
ROE13.42%
ROA5.93%
Debt/Equity23.68
P/B Ratio1.8
Op. Cash FlowCN¥3.2B
Free Cash FlowCN¥2.1B
Industry P/E30.6
Technical Analysis
TrendBearish
RSI35.4
SupportCN¥25.74
ResistanceCN¥31.27
MA 20CN¥28.36
MA 50CN¥29.67
MA 200CN¥32.90
MACDBearish
VolumeStable
Fear & Greed Index95.48
Valuation
Fair ValueCN¥35.51
Target PriceCN¥34.04
Upside/Downside27.15%
GradeUndervalued
TypeValue
Dividend Yield5.34%
Risk Assessment
Beta0.07
Volatility37.92%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.